Abstract 4141423: Bridging the Divide: Evaluating Outcomes Between the Sexes for Transcatheter Aortic Valve Replacement

Introduction: Sex-related short-term outcomes following transcatheter aortic valve replacement (TAVR) are known. There is less data comparing the long-term differences in outcomes between sexes. Studies suggest women are less likely to be referred for TAVR and have higher mortality. This study investigated the differences between genders and races on outcomes in the following 6 and 12 months post-TAVR. Questions: Are there differences in outcomes between males and females who undergo TAVR? Are there differences in outcomes between females of different races undergoing TAVR? Methods: We performed a retrospective cohort study among 252 patients undergoing TAVR between 2018 and 2023 at a major academic medical center in Chicago, Illinois. Primary outcomes included composite major adverse cardiac events (MACE) (CVA, MI and/or CVA) and all-cause death. Outcomes were analyzed at 6 and 12 months following TAVR. T and Chi square tests were used to analyze continuous/categorical variables respectively. Results: Among the 252 patients studied, 27.4% were female, 27.5% white, 47.8% black, 10.1% Hispanic/Latino, 14.45% other. Average age of females and males were 77 ± 1 years and 75 ± 0.74 years (p=0.2967), respectively. Males were more likely to be former smokers (p=0.000) and to drink more than 8 alcoholic beverages per week (p=0.023). No significant differences were seen between genders for MACE, all-cause death, CVA or MI at 6 or 12 months (Table 1). There were also no significant differences were found between females of different races for MACE, all-cause death, CVA, or MI at 6 or 12 months. There was a significant difference by race for development of conduction abnormalities found at 6-month follow-up (p=0.02). Conclusion: This study shows females appeared to have similar outcomes at 6 and 12 months following TAVR when compared to males. However, the possible causes leading to increased development of conduction abnormalities found at 6 months follow up between female racial groups needs to be further studied.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2024-11-12
DOI
https://doi.org/10.1161/circ.150.suppl_1.4141423
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4141423: Bridging the Divide: Evaluating Outcomes Between the Sexes for Transcatheter Aortic Valve Replacement

Manisha Singam, Farrah Nasrollahi, Julia Yu, Aleyah Hattab et al.
Circulation
Cardiac Valve Diseases and Treatments
article

Abstract 4141423: Bridging the Divide: Evaluating Outcomes Between the Sexes for Transcatheter Aortic Valve Replacement

Manisha Singam, Farrah Nasrollahi, Julia Yu, Aleyah Hattab, Andrew K. Carlson, Manoj Ambalavanan, Suhas Seshadri, Edward Salem, Adhir Shroff, Carlos Dohse, David Tiu, Mayank Mohan Kansal, Pranati Sreepathy, Helena Dickens, Ibrahim Khalil, Kayla Torres, Victor Qiao, Siddharth Bhayani, Samer Habeel, Daniel Tiu, Trang Dau, Mariam Ismail, Laura Navarro, Romani Wahba, Azmer Khan, Swetha Kalagara, Jesse Balami, Bayan Hammad, Zachary Natsheh
article en

Abstract

Introduction: Sex-related short-term outcomes following transcatheter aortic valve replacement (TAVR) are known. There is less data comparing the long-term differences in outcomes between sexes. Studies suggest women are less likely to be referred for TAVR and have higher mortality. This study investigated the differences between genders and races on outcomes in the following 6 and 12 months post-TAVR. Questions: Are there differences in outcomes between males and females who undergo TAVR? Are there differences in outcomes between females of different races undergoing TAVR? Methods: We performed a retrospective cohort study among 252 patients undergoing TAVR between 2018 and 2023 at a major academic medical center in Chicago, Illinois. Primary outcomes included composite major adverse cardiac events (MACE) (CVA, MI and/or CVA) and all-cause death. Outcomes were analyzed at 6 and 12 months following TAVR. T and Chi square tests were used to analyze continuous/categorical variables respectively. Results: Among the 252 patients studied, 27.4% were female, 27.5% white, 47.8% black, 10.1% Hispanic/Latino, 14.45% other. Average age of females and males were 77 ± 1 years and 75 ± 0.74 years (p=0.2967), respectively. Males were more likely to be former smokers (p=0.000) and to drink more than 8 alcoholic beverages per week (p=0.023). No significant differences were seen between genders for MACE, all-cause death, CVA or MI at 6 or 12 months (Table 1). There were also no significant differences were found between females of different races for MACE, all-cause death, CVA, or MI at 6 or 12 months. There was a significant difference by race for development of conduction abnormalities found at 6-month follow-up (p=0.02). Conclusion: This study shows females appeared to have similar outcomes at 6 and 12 months following TAVR when compared to males. However, the possible causes leading to increased development of conduction abnormalities found at 6 months follow up between female racial groups needs to be further studied.

CirculationVol. 150(Suppl_1)
University of Miami (US), University of Illinois Chicago (US), Indo-American Center (US)
Good health and well-being
Openalex Percentile: Top 62%
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.